AMPHASTAR PHARMS INC FDA Approval ANDA 208600

ANDA 208600

AMPHASTAR PHARMS INC

FDA Drug Application

Application #208600

Application Sponsors

ANDA 208600AMPHASTAR PHARMS INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS, SUBCUTANEOUS300MG/3ML (100MG/ML)0ENOXAPARIN SODIUMENOXAPARIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2019-03-14STANDARD
LABELING; LabelingSUPPL2AP2022-11-15STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7

TE Codes

001PrescriptionAB

CDER Filings

AMPHASTAR PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208600
            [companyName] => AMPHASTAR PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ENOXAPARIN SODIUM","activeIngredients":"ENOXAPARIN SODIUM","strength":"300MG\/3ML (100MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/14\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-03-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.